Mutations in the p53 and SCID genes cooperate in tumorigenesis

Genes and Development

Volumn 10, Issue 16, 1996, Pages 2055-2066

  Nacht, Mariana ^a   Strasser, Andreas ^b   Chan, Yvonne R ^c,d   Harris, Alan W ^b   Schlissel, Mark ^e   Bronson, Roderick T ^f   Jacks, Tyler ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

p53; SCID; T cell development; tumorigenesis

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME SUBUNIT; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; HYPERSENSITIVITY; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0029858044     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.16.2055     Document Type: Article

References (47)

1. Agarwal, M.L., A. Agarwal, W.R. Taylor, and G.R. Stark. 1995. p53 controls both the G2/M and G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. 92: 8493-8497.
2. Biedermann, K.A., J. Sun, A.J. Giaccia, L.M. Tosto, and J.M. Brown. 1991. seid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair. Proc. Natl. Acad. Sci. 88: 1394-1397.
3. Blunt, T., N.J. Finnic, G.E. Taccioli, G.C.M. Smith, J. Demengeot, T.M. Gottlieb, R. Mizuta, A.J. Varghese, F.W. Alt, P.A. Jeggo, and S.P. Jackson. 1995. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80: 813-823.
4. Bogue, M.A., C. Zhu, E. Aguilar-Cordova, L.A. Donehower, and D.B. Roth. 1996. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes & Dev. 10: 553-565.
5. Bosma, M.J. and A.M. Carroll. 1991. The seid mouse mutant: Definition, characterization, and potential uses. Annu. Rev. Immunol. 9: 323-344.
6. Bosma, G.G., R.P. Custer, and M.J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301: 527-530.
7. Chiou, S.-K., L. Rao, and E. White. 1994. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14: 2556-2563.
8. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, G.G. Bird, M.L. Hooper, and A.M. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
9. Danska, J.S., F. Pflumio, C.J. Williams, O. Huner, J.E. Dick, and C.J. Guidos. 1994. Rescue of T cell-specific V(D)J recombination in SCID mice by DNA-damaging agents. Science 266: 450-456.
10. Donehower, L.A., M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery, J.S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
11. Fehling, H.J., A. Krotkova, C. Saint-Ruf, and H. Von Boehmer. 1995. Crucial role for the pre-T cell receptor alpha gene in development of αβ but not γδ T cells. Nature 375: 795-798.
12. Fulop, G.M. and R.A. Phillips. 1990. The seid mutation in mice causes a general defect in DNA repair. Nature 347: 479-482.
13. Godfrey, D.I. and A. Zlotnik. 1993. Control points in early T-cell development. Immunol. Today 14: 547-553.
14. Godfrey, D.I., J. Kennedy, T. Suda, and A. Zlotnik. 1993. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8-triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J. Immunol. 150: 4244-4252.
15. Godfrey, D.I., J. Kennedy, P. Mombaerts, S. Tonegawa, and A. Zlotnik. 1994. Onset of TCR-beta gene rearrangement and role of TCR-beta expression during CD3-CD4-CD8 thymocyte differentiation. J. Immunol. 152: 4783-4792.
16. Gottlieb, T.M. and S.P. Jackson. 1994. Protein kinases and DNA damage. Trends Biol. Sci. 19: 500-503.
17. Guidos, C.J., C.J. Williams, G.E. Wu, C.J. Paige, and J.S. Danska. 1995. Development of CD4 + CD8 + thymocytes in RAGdeficient mice through a T cell receptor beta chain-independent pathway. J. Exp. Med.. 181: 1187-1195.
18. Guillouf, C., F. Rosselli, K. Krishnaraju, E. Moustacchi, B. Hoffman, and D.A. Liebermann. 1995. p53 involvement in control of G2 exit of the cell cycle: Role in DNA damage-induced apoptosis. Oncogene 10: 2263-2270.
19. Harris, A. 1991. Mechanisms of B cell neoplasia. In Conference on mechanisms of B cell neoplasia (ed. F. Melchers and P. Michael), pp. 367-374. Editiones Roche, Basel, Switzerland.
20. Hecht, F. and B.K. Hecht. 1990. Cancer in Ataxia-telangiectasia patients. Cancer Genet. Cytogenet. 46: 9-19.
21. Hollstein, M., D. Sidransky, B. Vogelstein, and C.C. Harris. 1991. p53 mutations in human cancers. Science 253: 49-53.
22. Jacks, T., L. Remington, B.O. Williams, E.M. Schmitt, S. Halachmi, R.T. Bronson, and R.A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7.
23. Kastan, M., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
24. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R.W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311.
25. Kemp, C.J., T. Wheldon, and A. Balmain. 1994. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genet. 8: 66-69.
26. Kirchgessner, C.U., C.K. Patil, J.W. Evans, C.A. Cuomo, L.M. Fried, T. Carter, M.A. Oettinger, and J.M. Brown. 1995. DNA-dependent kinase |p350| as a candidate gene for the murine SCID defect. Science 267: 1178-1183.
27. Lane, D.P. 1993. A death in the life of p53. Nature 362: 786-787.
28. Lees-Miller, S.P., R. Godbout, D.W. Chan, M. Weinfeld, R.S. Day III, G.M. Barron, and J. Allalunis-Tumer. 1995. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267: 1183-1185.
29. Levelt, C.N., A. Ehrfeld, and K. Eichmann. 1993. Regulation of thymocyte development through CD3. I. Timepoint of ligation of CD3 ε determines clonal deletion or induction of developmental program. J. Exp. Med. 177: 707-716.
30. Levine, A.J., J. Momand, and C.A. Finlay. 1991. The p53 tumour suppressor gene. Nature 351: 453-456.
31. Lieber, M.R., J.E. Hesse, S. Lewis, G.C. Bosma, N. Rosenberg, K. Mizuuchi, M.J. Bosma, and M. Gellert. 1988. The defect in murine severe combined immune deficiency: Joining of signal sequences but not coding seqments in V(D)J recombination. Cell 55: 7-16.
32. Lowe, S.W., E.S. Schmitt, S.W. Smith, B.A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
33. Malkin, D. 1993. p53 and the Li-Fraumeni syndrome. Cancer Genet. Cytogenet. 66: 83-92.
34. Mombaerts, P., A.R. Clarke, M.A. Rudnicki, J. Iacomini, S. Itohara, J.J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M.L. Hooper, and S. Tonegawa. 1992. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 360: 225-231.
35. Morrell, D., E. Cromartie, and M. Swift. 1986. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J. Natl. Cancer Inst. 77: 89-92.
36. Powell, S.N., J.S. DeFrank, P. Connell, M. Eogan, F. Preffer, D. Dombkowski, W. Tang, and S. Friend. 1995. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55: 1643-1648.
37. Rolink, A. and F. Melchers. 1991. Molecular and cellular origins of B lymphocyte diversity. Cell 66: 1081-1094.
38. Schuler, W., I.J. Weiler, A. Schuler, R.A. Phillips, N. Rosenberg, T.W. Mak, J.F. Keamey, R.P. Perry, and M.J. Bosma. 1986. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 46: 963-972.
39. Shinkai, Y., G. Rathbun, K.P. Lam, E.M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A.M. Stall, and F.W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
40. Strasser, A., A.W. Harris, and S. Cory. 1991. bcl-2 trangene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889-899.
41. Strasser, A., A.W. Harris, L.M. Corcoran, and S. Cory. 1994a. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature 368: 457-460.
42. Strasser, A., A.W. Harris, T. Jacks, and S. Cory. 1994b. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79: 329-339.
43. Wang, Y., L. Szekely, I. Okan, G. Klein, and K.G. Wiman. 1993. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T cell lymphoma line. Oncogene 8: 3427-3431.
44. Weaver, D.T. 1995. What to do at an end: DNA double-strandbreak repair. Trends Genet. 11: 388-392.
45. Weibezahn, K.F., H. Lohrer, and P. Herrlich. 1985. Doublestrand break repair and G2 block in Chinese hamster ovary cells and their radiosensitive mutants. Mutat. Res. 145: 177-183.
46. Ziegler, A., A.S. Jonason, D.J. Leffell, J.A. Simon, H.W. Sharma, J. Limmelman, L. Remington, T. Jacks, and D.E. Brash. 1994. Sunburn and p53 in the onset of skin cancer. Nature 372: 773-776.
47. Zuñiga-Pflucker, J.C., D. Jiang, P.L. Schwartzberg, and M.J. Lenardo. 1994. Sublethal γ-radiation induces differentiation of CD4 - /CD8 - into CD4 + /CD8 + thymocytes without T cell receptor β rearrangement in recombinase activation gene 2 - / - mice. J. Exp. Med. 180: 1517-1521.